Showing results (41-50 of 349) with videos related to

Sort By:
Pageof 35
Current Treatment Options in Oncology|June 22, 2005
Motexafin gadolinium induces oxidative stress and apoptosis in hematologic malignanciesAndrew M Evens, Lakshmi Balasubramanian, Leo I Gordon
Current Hematologic Malignancy Reports|June 6, 2013
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategiesZeina Al-Mansour, Beverly P Nelson, Andrew M Evens
Leukemia Research|July 6, 2004
The potential of arsenic trioxide in the treatment of malignant disease: past, present, and futureAndrew M Evens, Martin S Tallman, Ronald B Gartenhaus
Oncology (Williston Park, N.Y.)|December 18, 2008
Hodgkin lymphoma in older patients: an uncommon disease in need of studyAndrew M Evens, John W Sweetenham, Sandra J Horning
Cancer & Metabolism|October 12, 2022
Scaffold-mediated switching of lymphoma metabolism in cultureRachana Bhatt, Dashnamoorthy Ravi, Andrew M Evens, et al.
Blood|March 5, 2015
Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunitiesAthena Kritharis, Michael Coyle, Jaya Sharma, et al.
Current Treatment Options in Oncology|January 14, 2012
Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendationsDeepa Jagadeesh, Bruce A Woda, Jacqueline Draper, et al.
Current Treatment Options in Oncology|April 25, 2020
Current Treatment Options for Older Patients with Hodgkin LymphomaJordan Carter, Kevin A David, Athena Kritharis, et al.
Pageof 35